
Infectious Diseasesalbendazoleivermectin
Orodispersible Ivermectin and Moxidectin–Albendazole Combinations Deliver Major Gains Against Trichuris trichiura in Children: Dose‑response, Safety, and Programmatic Implications
By MedXY|Nov 24, 2025
Two randomized trials from Pemba Island show orodispersible ivermectin–albendazole yields dose‑dependent high cure rates in preschool children, and moxidectin–albendazole is superior to albendazole alone in school‑aged children, both with a
